Prison hepatitis c study pulled before it began
NCT ID NCT05649202
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to see if faster testing and treatment for hepatitis C could be given to inmates right when they enter prison. The goal was to start medication sooner to reduce the spread of the virus. However, the study was withdrawn and no one took part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS C VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Internal Medicine Service, Cochin Hospital (Consultation and Ambulatory Care Unit (UCSA) within the Paris-La Santé Penitentiary Center (CPPLS))
Paris, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood scores may identify low-risk patients after hepatitis c cure, reducing need for lifelong cancer scans
- French study maps hepatitis c subtypes to improve treatment
- New blood test could spot liver cancer sooner
- New HIV vaccine trial aims to spark rare antibodies that could fight the virus
- DNA vaccine trial aims to train immune system against hepatitis c